Aurobindo Pharma Ltd 2024 IR
The report highlights Aurobindo Pharma Limited's financial and sustainability performance for the fiscal year 2023-24. The company achieved its highest-ever operational revenue of INR 29,002 crore, representing a 17% year-on-year growth. Key operational milestones included the commercialisation of four major manufacturing facilities, including Penicillin-G and 6-APA plants, advancing its backward integration strategy. On the environmental front, the company reduced its carbon footprint by approximately 16% compared to the FY20 baseline and utilized 124,446 MWh of renewable energy. Additionally, the company recycled and reused 232,373 KL of treated wastewater and positively impacted 8.59 lakh lives through various CSR initiatives.
Company: Aurobindo Pharma Ltd
Sector: Health Care
Country: India
Year: 2024
Type: IR
Pages: 231
Aurobindo Pharma Ltd
Integrated Annual Report
The report highlights Aurobindo Pharma Limited's financial and sustainability performance for the fiscal year 2023-24. The company achieved its highest-ever operational revenue of INR 29,002 crore, representing a 17% year-on-year growth. Key operational milestones included the commercialisation of four major manufacturing facilities, including Penicillin-G and 6-APA plants, advancing its backward integration strategy. On the environmental front, the company reduced its carbon footprint by approximately 16% compared to the FY20 baseline and utilized 124,446 MWh of renewable energy. Additionally, the company recycled and reused 232,373 KL of treated wastewater and positively impacted 8.59 lakh lives through various CSR initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees